Research Paper Volume 12, Issue 11 pp 10162—10179

First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds

Figure 15. Metastasis prophylaxis: clinical implications of mitochondrial inhibitors for the prevention of treatment failure and cancer metastasis. Based on our current results, that mitochondrial inhibitors can selectively prevent metastasis, we suggest that these findings could be applied clinically to help prevent treatment failure in breast cancer patients.